Navigation Links
China Biologic Products Announces First Quarter 2008 Results Conference Call
Date:5/14/2008

TAI'AN CITY, Shandong, China, May 14 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP", "the Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that it will conduct a conference call at 5:00 p.m. Eastern Time on Thursday, May 15, 2008 to discuss the first quarter 2008 results.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 800- 688-0796. International callers should dial 617-614-4070. When prompted by the operator, mention Conference Passcode 991 762 11.

If you are unable to participate in the call at this time, a replay will be available for fourteen days starting on Thursday, May 15 at 7:00 p.m. Eastern Time. To access the replay, dial 888-286-8010, international callers should dial 617-801-6888, and enter the passcode 533 752 43.

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is currently the only plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province with a population of 93 million. The Company is engaged primarily in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Plasma-based Human Albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and treatment.

For more information please contact:

Company Contact:

Mr. Stanley Wong

CEO President

China Biologic Products, Inc.

Tel: +86-538-620-2306

Email: IR@chinabiologic.com

Website: http://www.chinabiologic.com

Investor Relations C
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ... of Dr. Alan Warrander to the role of ... ,, "Dr. Warrander will be responsible for the ... said Dr. Brad Thompson, President and CEO of ... of a Phase 3 trial examining REOLYSIN in ...
(Date:12/10/2009)... Institute (NEI), a division of the National Institutes of Health ... help fund its development of a non-invasive, passive diffusion-based treatment ... ... Salt Lake City, UT (PRWEB) December 10, 2009 ... National Institutes of Health (NIH), awarded a $2.18 million grant ...
(Date:12/10/2009)... China Biologic,Products, Inc. (Nasdaq: CBPO ) ("China ... biopharmaceutical companies in China, today announced,that the Company,s ... at the,NASDAQ MarketSite in New York City at ... China Biologic,s common stock ... 2, 2009, under the ticker symbol "CBPO." , ...
(Date:12/10/2009)... DNDN ) today announced that Hans Bishop has ... 4, 2010. Mr. Bishop most recently served as ... he was responsible for a diverse portfolio of oncology, ... as an executive vice president of Bayer HealthCare LLC. ... management team, Mr. Bishop will be responsible for preparing ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3China Biologic Products to Ring NASDAQ Opening Bell 2China Biologic Products to Ring NASDAQ Opening Bell 3Dendreon Appoints Hans Bishop as Chief Operating Officer 2
... The Eniva Research Group has,released results ... Pauling,Micronutrient Research Institute at Oregon State University ... DNA protective,anti-mutagenic activity for human cells. This ... an ongoing investigative effort to further identify,mechanisms ...
... On June 27, 2008,GeneraMedix Inc. received approval ... its Epoprostenol for Injection 1.5 mg New Drug,Application ... indicated for the long-term,intravenous treatment of primary pulmonary ... of disease in NYHA,Class III and Class IV ...
... July 3 Advanced Life Sciences,Holdings, Inc. ... engaged in the,discovery, development and commercialization of ... cancer and respiratory diseases, today,announced that it ... after the,Russell Investment Group reconstituted its comprehensive ...
Other Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg 2Advanced Life Sciences Added to Russell Microcap Index 2Advanced Life Sciences Added to Russell Microcap Index 3
(Date:12/11/2009)... ROUGE, LAKeeping with the global "green" trend, ... education lessons to enhance students, science knowledge. ... into the curriculum raises not just science ... scores in other subject areas. Naturally, educators ... integrate these relevant lessons into the classroom ...
(Date:12/11/2009)... under stress collectively weigh and initiate different survival strategies ... make strategic decisions that affect their health, wealth and ... published this week in the early online edition of ... Sciences , was accomplished when the scientists applied the ... interplay of genes and proteins that colonies of bacteria ...
(Date:12/11/2009)... This release is available in French . ... have discovered a novel molecular mechanism that prevents cancer. ... Molecular Cell , scientists from the Universit de ... found that the SOCS1 molecule prevents the cancer-causing activity ... inflammation diseases such as Crohns, in smokers and people ...
Breaking Biology News(10 mins):Students learn environmental stewardship, improve science scores 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5Scientists identify natural anti-cancer defenses 2Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 1Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 2Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 3Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First Aid Brochure 62322 4Cell Therapeutics Inc 28CTI 29 Piper Jaffray Presentation to be Webcast 62317 1Childhood lead exposure causes permanent brain damage 62312 1Childhood lead exposure causes permanent brain damage 62312 2
... 2008] Three-quarters of youths with type 1 diabetes were ... a study by researchers at the Joslin Diabetes Center ... D supplementation to prevent bone fragility later in life. , ... D inadequacy," said Lori Laffel, M.D., M.P.H., Chief of the ...
... A newly published genome sequence of a breast ... blueprint involving breaks and fusions of genes and a ... of Medicine in a report that appears online in ... a computer program that has become buggy and transcends ...
... new family of fluorescent probes called hydrocyanines that can ... reactive oxygen species. Reactive oxygen species are highly reactive ... variety of inflammatory diseases, including cancer and atherosclerosis. , ... to detect the reactive oxygen species, superoxide and ...
Other Biology News:Joslin research finds nearly three-quarters of youths with diabetes insufficient in vitamin D 2Breast cancer genome shows evolution, instability of cancer 2Breast cancer genome shows evolution, instability of cancer 3Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 2Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 3
... The Jouan RCT series of refrigerated ... suited to trapping of low volatility/aqueous solvents ... with RC10 and other vacuum concentrators/centrifugal evaporators. ... in cooling systems such as used in ...
96 Well Plate Sterile, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
...
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
Biology Products: